To hear about similar clinical trials, please enter your email below
Trial Title:
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
NCT ID:
NCT05978128
Condition:
Breast Carcinoma
Lung Carcinoma
Conditions: Official terms:
Carcinoma
Breast Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Screening
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Health Education
Description:
Access electronic patient portal with educational material
Arm group label:
Screening (electronic patient portal, patient navigation)
Intervention type:
Other
Intervention name:
Health Promotion and Education
Description:
Receive materials on breast/lung cancer screening
Arm group label:
Screening (electronic patient portal, patient navigation)
Intervention type:
Behavioral
Intervention name:
Patient Navigation
Description:
Interact with a patient navigator
Arm group label:
Screening (electronic patient portal, patient navigation)
Other name:
Patient Navigator Program
Intervention type:
Other
Intervention name:
Survey Administration
Description:
Ancillary studies
Arm group label:
Screening (electronic patient portal, patient navigation)
Summary:
This clinical trial assesses the use of advocates and supporters of breast and lung
cancer screening to increase lung cancer screening rates amongst eligible participants.
Imaging-based cancer screening is utilized with variable frequency. Breast cancer
screening with mammography has been widely accepted and is commonly used among eligible
women. Lung screening with computed tomography scans is poorly used, despite the
potential to decrease deaths from lung cancer. There are many reasons lung screening
isn't being used when compared to breast screening, such as smoking stigma and fear,
along with a lack of awareness of lung screening. By conducting this trial, researchers
want to assess the effectiveness of advocates and supporters of breast and lung
screening, and to learn about the psychological barriers to cancer screening, identifying
those that are unique to lung screening.
Detailed description:
PRIMARY OBJECTIVES:
I. Determine the number of patients undergoing breast screening who are eligible to
participate in lung screening.
II. Determine whether patients currently participating in cancer screening (breast OR
lung) are successful as "cancer screening advocates." III. Determine whether laypersons
who are aware of screening (including those who accompany friends and family members to
their screening appointments) are successful as "cancer screening advocates." IV.
Identify knowledge base and psychological barriers to screening through surveys of
potential screening participants.
OUTLINE:
Participants access an electronic patient portal with educational materials at baseline,
1- and 2-year follow-ups, and also interact with a patient navigator on study. Patients
also receive materials to share with their friends/family on benefits of breast and lung
cancer screening on study.
After completion of study intervention, participants are followed up yearly for up to 3
years.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Age:
- Breast screening > 40
- Lung screening 50-80
- Male (M) or Female (F)
- Current, former, or never smokers
- Close family or friend with smoking history (in or out of state)
Exclusion Criteria:
- Age:
- Breast screening < 40
- Lung screening < 50 or > 80
- Persons who had previously received a diagnosis of lung cancer, had hemoptysis, or
had an unexplained weight loss of more than 6.8 kg (15 lb) in the preceding year
will also be excluded
- Persons with an active cancer
Gender:
All
Minimum age:
40 Years
Maximum age:
80 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
UCLA / Jonsson Comprehensive Cancer Center
Address:
City:
Los Angeles
Zip:
90095
Country:
United States
Status:
Recruiting
Contact:
Last name:
Ashley E. Prosper
Phone:
310-825-0958
Email:
APROSPER@MEDNET.UCLA.EDU
Investigator:
Last name:
Ashley E. Prosper
Email:
Principal Investigator
Start date:
July 28, 2023
Completion date:
September 30, 2029
Lead sponsor:
Agency:
Jonsson Comprehensive Cancer Center
Agency class:
Other
Source:
Jonsson Comprehensive Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05978128
